Nymox Pharmaceutical Corporation (NASDAQ:NYMX) has lost 2.75% to settle at $9.80 with a volume of 62,200. For the past 52 weeks the stock has been trading between $6.52 and $11.26 with an average volume of 48,115. Company has a market cap of $224 million and a beta of 1.44.
Nymox Pharmaceutical Corporation (Nymox) is a biopharmaceutical company. As of December 31, 2009, the Company has three products on the market, and a research and development (R&D) pipeline of drug and diagnostic products in development. The Company markets the AlzheimAlert test as an aid to the diagnosis of Alzheimer's disease. Nymox also markets NicAlert and TobacAlert, its two products, which determine a person's level of exposure to tobacco products.
Sify Technologies (NASDAQ:SIFY) has gained 2.32% to settle at $3.09 with a volume of 1.60 7 million shares. For the past 52 weeks the stock has been trading between $1.18 and $3.56 with an average volume of 780,000 shares. Company has a market cap of $165 million and a beta of 3.1.
Sify Technologies Limited (Sify) is an integrated Internet, network and electronic commerce services companies in India, offering end-to-end solutions with a range of services delivered over a common Internet backbone infrastructure. The Company's services enable its business and consumer customers to communicate, transmit and share information, access online content and conduct business remotely using its private data network or the Internet.
Argan, Inc. (AMEX:AGX) has lost 0.72% to settle at $8.30 a share with a volume of 49,000 shares. For the past 52 weeks the stock has been trading between $7.40 and $15.24 with an average volume of 13,600 shares. Company has a market cap of $113 million and a beta of 0.47.
Sify Technologies Limited (Sify) is an integrated Internet, network and electronic commerce services companies in India, offering end-to-end solutions with a range of services delivered over a common Internet backbone infrastructure. The Company's services enable its business and consumer customers to communicate, transmit and share information, access online content and conduct business remotely using its private data network or the Internet.
StoneMor Partners (NASDAQ:STON) has lost 2.77% to settle at $25.21 with a volume of 489,000 shares. For the past 52 weeks the stock has been trading between $18.01 and $33.51 with an average volume of 250,000 shares. Company has a market cap of $469 million and a beta of 0.88.
StoneMor Partners L.P. owns and operates cemeteries in the United States. As of December 31, 2009, the Company operated 235 cemeteries in 24 states and Puerto Rico. The Company owns 219 of these cemeteries, and it operates the remaining 16 under under management or operating agreements with the cemetery corporations that own the cemeteries. As of December 31, 2009, it also owned, operated and/or 58 funeral homes in 16 states and in Puerto Rico. 26 of these funeral homes are located on the grounds of the cemeteries that it owns.
Repros Therapeutics (NASDAQ:RPRX) has lost 3.41% to settle at $5.39 a share with a volume of 1 million shares. For the past 52 weeks the stock has been trading between $1.11 and $6.85 with an average greatvolume of 650,000 shares.
Repros Therapeutics Inc. (RPRX) is a development-stage biopharmaceutical company focused on the development of oral small molecule drugs for unmet medical needs. Its product pipeline consists of Androxal and Proellex. Androxal (male reproductive health) completed Phase 2b proof-of-concept trial in men treated for low testosterone levels who want to improve or maintain their fertility and/or sperm number and function, and its Investigational New Drug Application (IND), for the study of oral Androxal in the treatment of hypogonadal men with type II diabetes was accepted by the United States Food and Drug Administration (FDA).
OTCPicks.com is not a registered investment advisers or broker/dealer. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.
Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.
Disclosure: OTCpicks.com has not been compensated for any current or recent stocks listed in this stock news report
